This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Influenza

  1. Despite the critical role that medical oxygen plays in the treatment for numerous disease areas, many health facilities still lack access to this lifesaving treatment. This situation is often attributed to the cost of oxygen and related infrastructure; in reality, oxygen access barriers are complex and rarely linked to a single factor. Understanding the prevailing business models for oxygen production, storage, distribution, and delivery can provide important context as to how and why oxygen provision is limited in many countries. Scaling up oxygen globally will require significant shifts in many of the current business models prevalent in low- and middle-income countries.COVID-19 has cast a spotlight on oxygen, a health area that has long been neglected by the global community. With this attention, it is critical that decision-makers and implementers understand the complexities of the oxygen ecosystem, the various business models that comprise it, and how they impact patient access. This brief introduces the oxygen ecosystem that business models operate within and then outlines four types of business models: bulk supply agreements, cash-and-carry filling stations, direct equipment purchases, and equipment leasing.
    Published: October 2021
    Type: Resource Page
  2. In West Africa and around the world, scaling up access to oxygen is one of the most effective, and critical, actions that decision-makers can take to improve health outcomes, particularly for vulnerable populations such as newborns, children, and pregnant women. The COVID-19 pandemic has further emphasized the vital role of respiratory care for patients struggling to breathe. Respiratory care requires investment in strengthening health care delivery systems, including supply management and provider training.This brief summarizes Senegal’s and Burkina Faso’s efforts toward establishing a comprehensive and sustainable oxygen system to address respiratory care needs beyond COVID-19, and demonstrates the type of support PATH can provide in this process.
    Published: October 2021
    Type: Resource Page
  3. Why is vaccination in pregnancy—or maternal immunization— important for public health? Here are 10 reasons.
    Published: October 2021
    Type: Article
  4. As part of the global response to the COVID-19 pandemic, there has been a proliferation of procurement options providing respiratory care equipment and related services to treat severe and critical COVID-19 patients. However, there is limited awareness of the various procurement options available to prospective buyers and how to utilize them.This summary brief highlights respiratory care equipment procurement options and organizations that play a pivotal role in financing, coordinating, and conducting such procurements. It aims to increase awareness of the various procurement options available to prospective respiratory care equipment buyers—such as public procurement entities at national and subnational levels, public and private health facilities, and nongovernmental organizations—in order to inform purchasing decisions. It also aims to strengthen coordination among the global respiratory care equipment community by increasing understanding of each organization’s offerings and capabilities.
    Published: August 2021
    Type: Resource Page
  5. This landscape of respiratory care equipment distributors across sub-Saharan Africa is intended to provide market insights into distributors in the region who can provide quality products and after-sales support. The distributors represented in this landscape were prioritized based on their geographic reach, quality assurance, and/or strong after-sales services. Each company completed a survey about their respective capabilities and engaged in follow-up discussions to further clarify their offerings. In this version (November 2021), products with stringent regulatory authority (SRA) approval were prioritized for inclusion. We will continue to build on this landscape as further engagement takes place.If your company supplies respiratory care equipment, has presence in sub-Saharan Africa, and would like to be considered for inclusion, please complete this short survey.
    Published: July 2021
    Type: Resource Page
  6. A great deal of knowledge already exists in the global health community regarding maternal, neonatal, and child health (MNCH) medical devices and the challenges/barriers they face. But this knowledge is currently scattered across a variety of donor, partner, country, and academic sources, and as a result, is not easily accessible to the broader community. As such, PATH—under the Market Dynamics for MNCH Medical Devices project (MD4MD)—conducted a rapid desk research exercise focused on compiling information that was either publicly available or easily accessible, including: published literature, multilateral organization resources (such as policy briefs, technical reports, and guidelines); implementing partner projects (such as assessments, landscapes, and technical reports); donor investment documents; and expert interviews with relevant project leads and medical device experts.This evidence review focuses on eight specific devices: (1) manual blood pressure cuff (sphygmomanometer); (2) electric bCPAP device; (3) neonatal resuscitation device; (4) x-ray radiography machine; (5) point-of-care hemoglobin meter; (6) infusion device; (7) ultrasound (app-based “pocket” devices); and (8) ultrasound (traditional portable devices).The goal of these documents is to (1) summarize for policymakers and health system leaders the most important barriers that MNCH devices face, and (2) highlight potential interventions and key knowledge gaps to prioritize with future investments.
    Published: July 2021
    Type: Resource Page
  7. Together with over 400 external stakeholders from across 50 countries, PATH has crafted a new institutional strategy that responds to the current crises we face as a global community, to the needs and priorities of our local partners, and to the resounding calls for the continued transformation of our sector. To bring our new strategy to life for our external partners, we’ve developed a strategy brochure. The brochure explains why PATH exists (our mission), what we will do (our priorities) and, perhaps most importantly, how we will do it (our change strategies).
    Published: June 2021
    Type: Resource Page
  8. The COVID-19 pandemic has highlighted the need for oxygen and other respiratory care supplies and equipment around the globe.In response, PATH conducted a biomedical equipment survey in eight government-owned health facilities in Zambia. The purpose of this survey was to quantify existing oxygen delivery and production equipment, consumables for administering oxygen therapy, bed capacity, and facility infrastructure characteristics that are relevant to providing respiratory care. The results indicated that all assessed institutions need urgent procurement of medical equipment for oxygen delivery, monitoring devices to support safe oxygen administration to patients, and accompanying consumables. Also, across all facilities there is insufficient staff trained to adequately manage COVID-19 patients requiring respiratory care.This report summarizes observations from the collected data and is intended to help global and national stakeholders understand COVID-19 treatment capacity in Zambia.
    Published: May 2021
    Type: Resource Page
  9. PATH has been a trusted partner to Vietnam’s Ministry of Health for four decades. We’ve supported its work to expand sexual, reproductive, maternal, and child health services, and to address infectious and vaccine-preventable diseases. Today, as rapid social and economic changes transform Vietnam, we are leveraging our thought leadership with the government, the private sector, civil-society organizations, and social entrepreneurs to advance equitable access to good health. Specific efforts include developing sustainable responses to diseases like HIV and tuberculosis (TB); supporting local stakeholders to develop their own health solutions, like domestically produced vaccines; and acting quickly to address new and emerging health threats, such as non-communicable diseases, hospital infections, drug resistance, and environmental dangers.
    Published: June 2019
    Type: Resource Page
  10. This fact sheet describes PATH’s work in maternal immunization—an approach of vaccinating during pregnancy to protect a mother and/or her infant. It covers work across vaccine projects targeting respiratory syncytial virus, Group B Streptococcus, influenza, and pertussis—infections that disproportionately threaten mothers and/or newborns.
    Published: May 2019
    Type: Resource Page
Load more